{
    "name": "levoleucovorin",
    "comment": "Rx",
    "other_names": [
        "Fusilev",
        "Khapzory"
    ],
    "classes": [
        "Antidotes",
        "Other"
    ],
    "source": "https://reference.medscape.com/drug/khapzory-fusilev-levoleucovorin-999760",
    "pregnancy": {
        "common": [
            "There are limited data in pregnant women",
            "Drug is administered in combination with methotrexate or fluorouracil, which can cause embryo-fetal harm; refer to methotrexate and fluorouracil prescribing information for additional information",
            "Animal data",
            "Animal reproduction studies not conducted "
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "There are no data on presence of levoleucovorin in human milk or effects on breastfed infant or on milk production",
            "Levoleucovorin is administered in combination with methotrexate or fluorouracil; refer to methotrexate and fluorouracil prescribing information for additional information"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity reactions to leucovorin products, folic acid, or folinic acid"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Increased gastrointestinal toxicities with 5-FU; monitor patients for gastrointestinal toxicities; do not initiate or continue therapy with fluorouracil in patients with symptoms of gastrointestinal toxicity until those symptoms have resolved",
                "Do not initiate or continue therapy with levoleucovorin and 5-FU in patients with symptoms of gastrointestinal toxicity until symptoms resolve; monitor patients with diarrhea until it resolves",
                "Increased rates of treatment failure and morbidity with concomitant use of d,l-leucovorin with trimethoprim-sulfamethoxazole for Pneumocystis jiroveci pneumonia in patients with HIV",
                "Exercise caution when taking folinic acid in combination with anticonvulsant drugs"
            ],
            "specific": [
                {
                    "type": "Drug interaction overview",
                    "description": [
                        "Increased rates of failure and morbidity in the acute treatment of Pneumocystis jiroveci pneumonia in HIV patients when coadministered with trimethoprim-sulfamethoxazole",
                        "Folic acid in large amounts may counteract the antiepileptic effect of phenobarbital, phenytoin and primidone and increase frequency of seizures in susceptible children; it is not known whether folinic acid has the same effects; however, both folic and folinic acids share some common metabolic pathways; monitor patients taking folinic acid in combination with antiepileptic drugs",
                        "Leucovorin products increase the toxicity of fluorouracil; do not initiate or continue therapy with fluorouracil in patients with symptoms of gastrointestinal toxicity until those symptoms have resolved; monitor patients with diarrhea until diarrhea has resolved, as rapid deterioration leading to death can occur"
                    ]
                }
            ]
        }
    },
    "interactions": [
        {
            "classification_type": "Serious",
            "interaction_with": "trimethoprim",
            "description": {
                "common": "levoleucovorin decreases effects of trimethoprim by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Monitor for trimethoprim treatment failure or decreased efficacy when coadministered with levoleucovorin, especially when used with sulfamethoxazole for  Pneumocystis jiroveci pneumonia in patients who are HIV positive ."
            }
        }
    ],
    "adverse effects": [
        {
            "name": "Diarrhea",
            "percent": "19"
        },
        {
            "name": "Stomatitis",
            "percent": "12"
        },
        {
            "name": "Nausea",
            "percent": "8"
        },
        {
            "name": "Vomiting",
            "percent": "5"
        },
        {
            "name": "Asthenia",
            "percent": "5"
        },
        {
            "name": "fatigue",
            "percent": "4"
        },
        {
            "name": "malaise",
            "percent": "3"
        },
        {
            "name": "Anorexia",
            "percent": "1"
        },
        {
            "name": "decreased appetite",
            "percent": null
        },
        {
            "name": "Abdominal pain",
            "percent": null
        },
        {
            "name": "Dermatitis",
            "percent": null
        }
    ]
}